• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤抑制因子Smad4突变失活的结构基础。

A structural basis for mutational inactivation of the tumour suppressor Smad4.

作者信息

Shi Y, Hata A, Lo R S, Massagué J, Pavletich N P

机构信息

Cellular Biochemistry and Biophysics Program, Memorial Sloan-Kettering Cancer Center, New York 10021, USA.

出版信息

Nature. 1997 Jul 3;388(6637):87-93. doi: 10.1038/40431.

DOI:10.1038/40431
PMID:9214508
Abstract

The Smad4/DPC4 tumour suppressor is inactivated in nearly half of pancreatic carcinomas and to a lesser extent in a variety of other cancers. Smad4/DPC4, and the related tumour suppressor Smad2, belong to the SMAD family of proteins that mediate signalling by the TGF-beta/activin/BMP-2/4 cytokine superfamily from receptor Ser/Thr protein kinases at the cell surface to the nucleus. SMAD proteins, which are phosphorylated by the activated receptor, propagate the signal, in part, through homo- and hetero-oligomeric interactions. Smad4/DPC4 plays a central role as it is the shared hetero-oligomerization partner of the other SMADs. The conserved carboxy-terminal domains of SMADs are sufficient for inducing most of the ligand-specific effects, and are the primary targets of tumorigenic inactivation. We now describe the crystal structure of the C-terminal domain (CTD) of the Smad4/DPC4 tumour suppressor, determined at 2.5 A resolution. The structure reveals that the Smad4/DPC4 CTD forms a crystallographic trimer through a conserved protein-protein interface, to which the majority of the tumour-derived missense mutations map. These mutations disrupt homo-oligomerization in vitro and in vivo, indicating that the trimeric assembly of the Smad4/DPC4 CTD is critical for signalling and is disrupted by tumorigenic mutations.

摘要

Smad4/DPC4肿瘤抑制因子在近半数的胰腺癌中失活,在其他多种癌症中失活程度较小。Smad4/DPC4以及相关的肿瘤抑制因子Smad2属于SMAD蛋白家族,该家族介导从细胞表面的受体丝氨酸/苏氨酸蛋白激酶到细胞核的TGF-β/激活素/BMP-2/4细胞因子超家族的信号传导。被激活的受体磷酸化的SMAD蛋白部分通过同型和异型寡聚体相互作用来传递信号。Smad4/DPC4起着核心作用,因为它是其他SMAD蛋白共同的异型寡聚化伙伴。SMAD蛋白保守的羧基末端结构域足以诱导大多数配体特异性效应,并且是致瘤失活的主要靶点。我们现在描述了Smad4/DPC4肿瘤抑制因子C末端结构域(CTD)的晶体结构,分辨率为2.5埃。该结构表明,Smad4/DPC4 CTD通过一个保守的蛋白质-蛋白质界面形成晶体学三聚体,大多数肿瘤来源的错义突变都定位在这个界面上。这些突变在体外和体内破坏了同型寡聚化,表明Smad4/DPC4 CTD的三聚体组装对于信号传导至关重要,并且会被致瘤突变破坏。

相似文献

1
A structural basis for mutational inactivation of the tumour suppressor Smad4.肿瘤抑制因子Smad4突变失活的结构基础。
Nature. 1997 Jul 3;388(6637):87-93. doi: 10.1038/40431.
2
DPC4 (SMAD4) mediates transforming growth factor-beta1 (TGF-beta1) induced growth inhibition and transcriptional response in breast tumour cells.DPC4(SMAD4)介导转化生长因子-β1(TGF-β1)诱导的乳腺肿瘤细胞生长抑制和转录反应。
Oncogene. 1997 Apr 24;14(16):1891-9. doi: 10.1038/sj.onc.1201017.
3
Functional mapping of the MH1 DNA-binding domain of DPC4/SMAD4.DPC4/SMAD4的MH1 DNA结合结构域的功能图谱
Nucleic Acids Res. 2000 Jun 15;28(12):2363-8. doi: 10.1093/nar/28.12.2363.
4
Activation of transforming growth factor-beta signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4.通过肿瘤抑制因子Smad4/DPC4的小泛素样修饰物1(SUMO-1)修饰激活转化生长因子-β信号通路
J Biol Chem. 2003 May 23;278(21):18714-9. doi: 10.1074/jbc.M302243200. Epub 2003 Mar 5.
5
Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes.Smad4/DPC4肿瘤抑制因子在转化生长因子β诱导的转录复合物中的双重作用
Genes Dev. 1997 Dec 1;11(23):3157-67. doi: 10.1101/gad.11.23.3157.
6
Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.肿瘤抑制因子Smad2和Smad4中的突变通过将Smads靶向泛素-蛋白酶体途径来使转化生长因子β信号失活。
Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4820-5. doi: 10.1073/pnas.97.9.4820.
7
Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4.增加自身抑制作用的突变可使肿瘤抑制因子Smad2和Smad4失活。
Nature. 1997 Jul 3;388(6637):82-7. doi: 10.1038/40424.
8
Differential ubiquitination defines the functional status of the tumor suppressor Smad4.差异化泛素化定义了肿瘤抑制因子Smad4的功能状态。
J Biol Chem. 2003 Aug 29;278(35):33571-82. doi: 10.1074/jbc.M300159200. Epub 2003 Jun 5.
9
Crystal structure of a transcriptionally active Smad4 fragment.转录活性Smad4片段的晶体结构
Structure. 1999 Dec 15;7(12):1493-503. doi: 10.1016/s0969-2126(00)88340-9.
10
Mutations of the DPC4/Smad4 gene in biliary tract carcinoma.
Cancer Res. 1998 Mar 15;58(6):1124-6.

引用本文的文献

1
Mutations in tumor signaling, metastases, and synthetic lethality establish distinct patterns.肿瘤信号传导、转移和合成致死性方面的突变呈现出不同的模式。
PLoS Comput Biol. 2025 Aug 4;21(8):e1013351. doi: 10.1371/journal.pcbi.1013351. eCollection 2025 Aug.
2
SMAD2 S-palmitoylation promotes its linker region phosphorylation and T17 cell differentiation in a mouse model of multiple sclerosis.在多发性硬化症小鼠模型中,SMAD2的S-棕榈酰化促进其连接区磷酸化和T17细胞分化。
Sci Signal. 2025 May 27;18(888):eadr2008. doi: 10.1126/scisignal.adr2008.
3
Gain-of-function variants in SMAD4 compromise respiratory epithelial function.
SMAD4功能获得性变异损害呼吸道上皮功能。
J Allergy Clin Immunol. 2025 Jan;155(1):107-119.e2. doi: 10.1016/j.jaci.2024.08.024. Epub 2024 Sep 5.
4
Phenotypic characterisation of variant carriers.变异携带者的表型特征分析。
J Med Genet. 2024 Jul 19;61(8):734-740. doi: 10.1136/jmg-2023-109632.
5
EMT Dynamics in Lymph Node Metastasis of Oral Squamous Cell Carcinoma.口腔鳞状细胞癌淋巴结转移中的上皮-间质转化动态变化
Cancers (Basel). 2024 Mar 18;16(6):1185. doi: 10.3390/cancers16061185.
6
The TGF-β superfamily as potential therapeutic targets in pancreatic cancer.转化生长因子-β超家族作为胰腺癌潜在的治疗靶点
Front Oncol. 2024 Mar 4;14:1362247. doi: 10.3389/fonc.2024.1362247. eCollection 2024.
7
Unexpected Differences in the Speed of Non-Malignant versus Malignant Cell Migration Reveal Differential Basal Intracellular ATP Levels.非恶性细胞与恶性细胞迁移速度的意外差异揭示了不同的基础细胞内ATP水平。
Cancers (Basel). 2023 Nov 22;15(23):5519. doi: 10.3390/cancers15235519.
8
Multi-omic stratification of the missense variant cysteinome.错义变异半胱氨酸组的多组学分层
bioRxiv. 2023 Aug 14:2023.08.12.553095. doi: 10.1101/2023.08.12.553095.
9
Proactive and reactive roles of TGF-β in cancer.TGF-β 在癌症中的主动和被动作用。
Semin Cancer Biol. 2023 Oct;95:120-139. doi: 10.1016/j.semcancer.2023.08.002. Epub 2023 Aug 11.
10
Disruptor: Computational identification of oncogenic mutants disrupting protein-protein and protein-DNA interactions.Disruptor:计算识别致癌突变体破坏蛋白质-蛋白质和蛋白质-DNA 相互作用的方法。
Commun Biol. 2023 Jul 13;6(1):720. doi: 10.1038/s42003-023-05089-2.